d-alpha tocopherol has been researched along with imatinib mesylate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arock, M; Azzi, A; Kempná, P; Reiter, E; Zingg, JM | 1 |
| Blasiak, J; Czechowska, A; Drzewoski, J; Poplawski, T | 1 |
| Krcmová, L; Melichar, B; Opletalová, V; Solich, P; Solichová, D; Urbánek, L | 1 |
| Dvorák, J; Holecková, P; Hyšpler, R; Kalábová, H; Kašparová, M; Krcmová, L; Melichar, B; Plíšek, J; Solichová, D; Tichá, A | 1 |
| Hochhaus, A; Hoser, G; Nieborowska-Skorska, M; Skorski, T; Stoklosa, T | 1 |
| Chen, Y; Cheng, Y; He, C; Li, M; Ma, X; Xiang, G; Yan, R; Yang, T; Ye, P; Zhang, S; Zhang, X; Zhao, P | 1 |
1 trial(s) available for d-alpha tocopherol and imatinib mesylate
| Article | Year |
|---|---|
Intestinal permeability, vitamin A absorption and serum alpha-tocopherol in gastrointestinal stromal tumor patients treated with imatinib.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antineoplastic Agents; Benzamides; Dietary Sucrose; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Absorption; Intestinal Mucosa; Male; Middle Aged; Permeability; Piperazines; Pyrimidines; Vitamin A | 2010 |
6 other study(ies) available for d-alpha tocopherol and imatinib mesylate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway.
Topics: Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hydrogen Peroxide; Imatinib Mesylate; Mast Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; ras Proteins; Signal Transduction; Time Factors; Tocopherols; U937 Cells; Vitamin E | 2004 |
Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Topics: Adult; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Benzamides; Comet Assay; DNA Damage; DNA Repair; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; Male; Piperazines; Plasmids; Protein-Tyrosine Kinases; Pyrimidines; Statistics, Nonparametric; Vitamin A; Vitamin E | 2005 |
Development and validation of a liquid chromatography method for the simultaneous determination of alpha-tocopherol, retinol and retinyl esters in human serum using a monolithic column for the monitoring of anticancer therapy side effects.
Topics: Absorption; alpha-Tocopherol; Antineoplastic Agents; Benzamides; Calibration; Chromatography; Chromatography, High Pressure Liquid; Diarrhea; Drug Monitoring; Esters; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Reproducibility of Results; Time Factors; Vitamin A | 2006 |
Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Benzamides; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interleukin Receptor Common gamma Subunit; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Piperazines; Pyrimidines; Vitamin E | 2013 |
Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Doxorubicin; Drug Liberation; Drug Resistance, Neoplasm; Drug Stability; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; Imatinib Mesylate; Liposomes; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Vitamin E | 2018 |